Yili Chuanning Biotechnology Co Ltd (301301)

Currency in CNY
12.35
-0.11(-0.88%)
Closed·
301301 Scorecard
Full Analysis
Has raised its dividend for 3 consecutive years
301301 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
12.3312.57
52 wk Range
10.4116.58
Key Statistics
Bid/Ask
12.35 / 12.35
Prev. Close
12.46
Open
12.42
Day's Range
12.33-12.57
52 wk Range
10.41-16.58
Volume
31.64M
Average Volume (3m)
34.99M
1-Year Change
-3.24%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
301301 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
15.00
Upside
+21.46%
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Biotechnology industry

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Yili Chuanning Biotechnology Co Ltd Company Profile

Yili Chuanning Biotechnology Co.,Ltd., together with its subsidiaries, engages in the research, development, and industrialization of bio-fermentation technology and synthetic biology products in China and internationally. The company offers antibiotic intermediates comprising erythromycin thiofluorate; cephalosporin intermediates consisting of 7-aminocephalosporanic acid (7-ACA), 7-amino-3-deacetoxycephalosporinic acid (7-ADCA), and D-7ACA; penicillin intermediates, such as 6-aminopenicillanic acid (6-APA) and penicillin G potassium salt; ursodeoxycholic acid; coenzyme Q10 mycelia; and other products. It also provides synthetic biology products, including bisabolol, 5-hydroxytryptophan, ergothioneine, ekdoin, inositol, squalane, polyhydroxyalkanoate (PHA), and phytosphingosine. In addition, the company engages in trading, crop planting, inspection, technical advisory, and asset investment activities. The company was incorporated in 2010 and is based in Yining, China. Yili Chuanning Biotechnology Co.,Ltd. is a subsidiary of Sichuan Kelun Pharmaceutical Co., Ltd.

Employees
3184
Market
China

Compare 301301 to Peers and Sector

Metrics to compare
301301
Peers
Sector
Relationship
P/E Ratio
20.9x37.6x−0.5x
PEG Ratio
1.02−1.390.00
Price/Book
3.4x2.3x2.6x
Price / LTM Sales
5.0x7.2x3.3x
Upside (Analyst Target)
20.4%4.1%43.5%
Fair Value Upside
Unlock10.9%6.9%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 15.00
(+21.46% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.60%
Dividend Yield
2.16%
Industry Median 1.51%
Annualised payout
0.27
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Apr 28, 2025
EPS / Forecast
0.13 / --
Revenue / Forecast
1.30B / --
EPS Revisions
Last 90 days

301301 Income Statement

FAQ

What Stock Exchange Does Yili Chuanning Biotechnology Trade On?

Yili Chuanning Biotechnology is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for Yili Chuanning Biotechnology?

The stock symbol for Yili Chuanning Biotechnology is "301301."

What Is the Yili Chuanning Biotechnology Market Cap?

As of today, Yili Chuanning Biotechnology market cap is 27.79B.

What Is Yili Chuanning Biotechnology's Earnings Per Share (TTM)?

The Yili Chuanning Biotechnology EPS (TTM) is 0.60.

When Is the Next Yili Chuanning Biotechnology Earnings Date?

Yili Chuanning Biotechnology will release its next earnings report on 27 Oct 2025.

From a Technical Analysis Perspective, Is 301301 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Yili Chuanning Biotechnology Stock Split?

Yili Chuanning Biotechnology has split 0 times.

How Many Employees Does Yili Chuanning Biotechnology Have?

Yili Chuanning Biotechnology has 3184 employees.

What is the current trading status of Yili Chuanning Biotechnology (301301)?

As of 07 Aug 2025, Yili Chuanning Biotechnology (301301) is trading at a price of 12.35, with a previous close of 12.46. The stock has fluctuated within a day range of 12.33 to 12.57, while its 52-week range spans from 10.41 to 16.58.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.